Obesity, inflammation, and the gut microbiota
Summary As the prevalence of obesity and associated disease continues to rise and concerns for the spiralling economic and social costs also escalate, innovative management strategies beyond primary prevention and traditional lifestyle interventions are urgently needed. The biological basis of disea...
Gespeichert in:
| Veröffentlicht in: | The lancet. Diabetes & endocrinology 2015-03, Vol.3 (3), p.207-215 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 215 |
|---|---|
| container_issue | 3 |
| container_start_page | 207 |
| container_title | The lancet. Diabetes & endocrinology |
| container_volume | 3 |
| creator | Cox, Amanda J, Dr West, Nicholas P, PhD Cripps, Allan W, Prof |
| description | Summary As the prevalence of obesity and associated disease continues to rise and concerns for the spiralling economic and social costs also escalate, innovative management strategies beyond primary prevention and traditional lifestyle interventions are urgently needed. The biological basis of disease is one avenue for further exploration in this context. Several key inflammatory markers have been consistently associated with both obesity and risk of adverse outcomes in obesity-associated diseases, which suggests that a persistent, low-grade, inflammatory response is a potentially modifiable risk factor. In this Review, we provide evidence supporting perturbation of the intestinal microbiota and changes in intestinal permeability as potential triggers of inflammation in obesity. Further characterisation of the mechanisms underpinning the triggers of such inflammatory responses in overweight and obese individuals could offer unique opportunities for intervention strategies to help ameliorate the risk of obesity-associated disease. |
| doi_str_mv | 10.1016/S2213-8587(14)70134-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1672087689</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S2213858714701342</els_id><sourcerecordid>1672087689</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-fb90ea07cf075c53d61ae7bea56423800bf2d46c81da8dc220fb3e486416b9e83</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EolXpJ4CyLFIDY8exnQ0IVbykSl0Aa8txJuCSR4kTpP496YMu2LAaa3TnzPgQck7higIV1y-M0ShUsZITyi8l0IiH7IgM9-0kPj68lRyQsfdLAKAQR0LBKRmwGISgUg5JuEjRu3Y9DVyVF6YsTevqahqYKgvaDwzeuzYonW3q1NWtOSMnuSk8jvd1RN4e7l9nT-F88fg8u5uHlkvWhnmaABqQNgcZ2zjKBDUoUzSx4CxSAGnOMi6soplRmWUM8jRCrgSnIk1QRSMy2XFXTf3VoW916bzFojAV1p3XVEgGSgqV9NF4F-1v9L7BXK8aV5pmrSnojSy9laU3JjTleitLs37uYr-iS0vMDlO_avrA7S6A_Ue_HTbaW4eVxcw1aFud1e7fFTd_CLZwlbOm-MQ1-mXdNVVvUVPtmYYdZMOgfEtg0Q8UMYwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1672087689</pqid></control><display><type>article</type><title>Obesity, inflammation, and the gut microbiota</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Cox, Amanda J, Dr ; West, Nicholas P, PhD ; Cripps, Allan W, Prof</creator><creatorcontrib>Cox, Amanda J, Dr ; West, Nicholas P, PhD ; Cripps, Allan W, Prof</creatorcontrib><description>Summary As the prevalence of obesity and associated disease continues to rise and concerns for the spiralling economic and social costs also escalate, innovative management strategies beyond primary prevention and traditional lifestyle interventions are urgently needed. The biological basis of disease is one avenue for further exploration in this context. Several key inflammatory markers have been consistently associated with both obesity and risk of adverse outcomes in obesity-associated diseases, which suggests that a persistent, low-grade, inflammatory response is a potentially modifiable risk factor. In this Review, we provide evidence supporting perturbation of the intestinal microbiota and changes in intestinal permeability as potential triggers of inflammation in obesity. Further characterisation of the mechanisms underpinning the triggers of such inflammatory responses in overweight and obese individuals could offer unique opportunities for intervention strategies to help ameliorate the risk of obesity-associated disease.</description><identifier>ISSN: 2213-8587</identifier><identifier>EISSN: 2213-8595</identifier><identifier>DOI: 10.1016/S2213-8587(14)70134-2</identifier><identifier>PMID: 25066177</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biomarkers ; Endocrinology & Metabolism ; Gastrointestinal Tract - metabolism ; Gastrointestinal Tract - microbiology ; Humans ; Inflammation - complications ; Inflammation - epidemiology ; Inflammation - metabolism ; Microbiota ; Models, Biological ; Obesity - complications ; Obesity - epidemiology ; Obesity - metabolism ; Other ; Permeability ; Prevalence</subject><ispartof>The lancet. Diabetes & endocrinology, 2015-03, Vol.3 (3), p.207-215</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-fb90ea07cf075c53d61ae7bea56423800bf2d46c81da8dc220fb3e486416b9e83</citedby><cites>FETCH-LOGICAL-c472t-fb90ea07cf075c53d61ae7bea56423800bf2d46c81da8dc220fb3e486416b9e83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25066177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cox, Amanda J, Dr</creatorcontrib><creatorcontrib>West, Nicholas P, PhD</creatorcontrib><creatorcontrib>Cripps, Allan W, Prof</creatorcontrib><title>Obesity, inflammation, and the gut microbiota</title><title>The lancet. Diabetes & endocrinology</title><addtitle>Lancet Diabetes Endocrinol</addtitle><description>Summary As the prevalence of obesity and associated disease continues to rise and concerns for the spiralling economic and social costs also escalate, innovative management strategies beyond primary prevention and traditional lifestyle interventions are urgently needed. The biological basis of disease is one avenue for further exploration in this context. Several key inflammatory markers have been consistently associated with both obesity and risk of adverse outcomes in obesity-associated diseases, which suggests that a persistent, low-grade, inflammatory response is a potentially modifiable risk factor. In this Review, we provide evidence supporting perturbation of the intestinal microbiota and changes in intestinal permeability as potential triggers of inflammation in obesity. Further characterisation of the mechanisms underpinning the triggers of such inflammatory responses in overweight and obese individuals could offer unique opportunities for intervention strategies to help ameliorate the risk of obesity-associated disease.</description><subject>Biomarkers</subject><subject>Endocrinology & Metabolism</subject><subject>Gastrointestinal Tract - metabolism</subject><subject>Gastrointestinal Tract - microbiology</subject><subject>Humans</subject><subject>Inflammation - complications</subject><subject>Inflammation - epidemiology</subject><subject>Inflammation - metabolism</subject><subject>Microbiota</subject><subject>Models, Biological</subject><subject>Obesity - complications</subject><subject>Obesity - epidemiology</subject><subject>Obesity - metabolism</subject><subject>Other</subject><subject>Permeability</subject><subject>Prevalence</subject><issn>2213-8587</issn><issn>2213-8595</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EolXpJ4CyLFIDY8exnQ0IVbykSl0Aa8txJuCSR4kTpP496YMu2LAaa3TnzPgQck7higIV1y-M0ShUsZITyi8l0IiH7IgM9-0kPj68lRyQsfdLAKAQR0LBKRmwGISgUg5JuEjRu3Y9DVyVF6YsTevqahqYKgvaDwzeuzYonW3q1NWtOSMnuSk8jvd1RN4e7l9nT-F88fg8u5uHlkvWhnmaABqQNgcZ2zjKBDUoUzSx4CxSAGnOMi6soplRmWUM8jRCrgSnIk1QRSMy2XFXTf3VoW916bzFojAV1p3XVEgGSgqV9NF4F-1v9L7BXK8aV5pmrSnojSy9laU3JjTleitLs37uYr-iS0vMDlO_avrA7S6A_Ue_HTbaW4eVxcw1aFud1e7fFTd_CLZwlbOm-MQ1-mXdNVVvUVPtmYYdZMOgfEtg0Q8UMYwg</recordid><startdate>20150301</startdate><enddate>20150301</enddate><creator>Cox, Amanda J, Dr</creator><creator>West, Nicholas P, PhD</creator><creator>Cripps, Allan W, Prof</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150301</creationdate><title>Obesity, inflammation, and the gut microbiota</title><author>Cox, Amanda J, Dr ; West, Nicholas P, PhD ; Cripps, Allan W, Prof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-fb90ea07cf075c53d61ae7bea56423800bf2d46c81da8dc220fb3e486416b9e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Biomarkers</topic><topic>Endocrinology & Metabolism</topic><topic>Gastrointestinal Tract - metabolism</topic><topic>Gastrointestinal Tract - microbiology</topic><topic>Humans</topic><topic>Inflammation - complications</topic><topic>Inflammation - epidemiology</topic><topic>Inflammation - metabolism</topic><topic>Microbiota</topic><topic>Models, Biological</topic><topic>Obesity - complications</topic><topic>Obesity - epidemiology</topic><topic>Obesity - metabolism</topic><topic>Other</topic><topic>Permeability</topic><topic>Prevalence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cox, Amanda J, Dr</creatorcontrib><creatorcontrib>West, Nicholas P, PhD</creatorcontrib><creatorcontrib>Cripps, Allan W, Prof</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The lancet. Diabetes & endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cox, Amanda J, Dr</au><au>West, Nicholas P, PhD</au><au>Cripps, Allan W, Prof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Obesity, inflammation, and the gut microbiota</atitle><jtitle>The lancet. Diabetes & endocrinology</jtitle><addtitle>Lancet Diabetes Endocrinol</addtitle><date>2015-03-01</date><risdate>2015</risdate><volume>3</volume><issue>3</issue><spage>207</spage><epage>215</epage><pages>207-215</pages><issn>2213-8587</issn><eissn>2213-8595</eissn><abstract>Summary As the prevalence of obesity and associated disease continues to rise and concerns for the spiralling economic and social costs also escalate, innovative management strategies beyond primary prevention and traditional lifestyle interventions are urgently needed. The biological basis of disease is one avenue for further exploration in this context. Several key inflammatory markers have been consistently associated with both obesity and risk of adverse outcomes in obesity-associated diseases, which suggests that a persistent, low-grade, inflammatory response is a potentially modifiable risk factor. In this Review, we provide evidence supporting perturbation of the intestinal microbiota and changes in intestinal permeability as potential triggers of inflammation in obesity. Further characterisation of the mechanisms underpinning the triggers of such inflammatory responses in overweight and obese individuals could offer unique opportunities for intervention strategies to help ameliorate the risk of obesity-associated disease.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25066177</pmid><doi>10.1016/S2213-8587(14)70134-2</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2213-8587 |
| ispartof | The lancet. Diabetes & endocrinology, 2015-03, Vol.3 (3), p.207-215 |
| issn | 2213-8587 2213-8595 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1672087689 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Biomarkers Endocrinology & Metabolism Gastrointestinal Tract - metabolism Gastrointestinal Tract - microbiology Humans Inflammation - complications Inflammation - epidemiology Inflammation - metabolism Microbiota Models, Biological Obesity - complications Obesity - epidemiology Obesity - metabolism Other Permeability Prevalence |
| title | Obesity, inflammation, and the gut microbiota |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A03%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Obesity,%20inflammation,%20and%20the%20gut%20microbiota&rft.jtitle=The%20lancet.%20Diabetes%20&%20endocrinology&rft.au=Cox,%20Amanda%20J,%20Dr&rft.date=2015-03-01&rft.volume=3&rft.issue=3&rft.spage=207&rft.epage=215&rft.pages=207-215&rft.issn=2213-8587&rft.eissn=2213-8595&rft_id=info:doi/10.1016/S2213-8587(14)70134-2&rft_dat=%3Cproquest_cross%3E1672087689%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1672087689&rft_id=info:pmid/25066177&rft_els_id=1_s2_0_S2213858714701342&rfr_iscdi=true |